GM10273
LCL from B-Lymphocyte
Description:
ANIRIDIA 1; AN1
TRANSLOCATED CHROMOSOME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Chromosome Abnormalities |
Class |
Ophthalmologic Disorders |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
ISCN
|
46,XX,t(11;22)(11qter>11p13::22q11.2 or 12.2>22qter;22pter>22q11.2 or 12.2:: 11p13>11pter)pat
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Cytogenetics |
Chromosome 11: TRANSLOCATION Breakpoint 11p13 t(11;22)11p13 |
|
Chromosome 22: TRANSLOCATION Breakpoint 22q11 t(11;22)22q11 |
|
Chromosome 22: TRANSLOCATION Breakpoint 22q12 t(11;22)22q12 |
Remarks |
Clinically affected; aniridia and nystagmus noted in newborn period; developmental delay noted at 9 months; brachydactyly of fifth digits; hemangioma of right labia majora; microcephaly; hypotonia; normal deep tendon reflexes; IQ=59; ophthalmologic exam in childhood revealed aniridia with rudimentary irides, bilateral exotropia, nystagmus, and foveal hypoplasia; glaucoma and bilateral subcapsular cataracts noted at age 4; no genitourinary tract abnormalities; familial chromosome translocation; father (GM10274), paternal half-brother(10272), and paternal grandmother also affected with aniridia and familial chromosome translocation; unaffected mother is GM10275; seven family members in 4 generations affected with aniridia but karyotype unknown. |
Moore JW, Hyman S, Antonarakis SE, Mules EH, Thomas GH, Familial isolated aniridia associated with a translocation involving chromosomes 11 and 22 [t(11;22)(p13;q12.2)]. Hum Genet72:297-302 1986 |
PubMed ID: 3754537 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
20% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|